Barosi G - Search Results

1

Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial.

Cazzola M, Ponchio L, Beguin Y, Rosti V, Bergamaschi G, Liberato NL, Fregoni V, Nalli G, Barosi G, Ascari E. Cazzola M, et al. Among authors: barosi g. Blood. 1992 Jan 1;79(1):29-37. Blood. 1992. PMID: 1728318 Free article. Clinical Trial.

2

Erythropoietin: biological aspects and clinical usefulness.

Liberato NL, Costa A, Barosi G. Liberato NL, et al. Among authors: barosi g. Haematologica. 1990 Jul-Aug;75(4):346-62. Haematologica. 1990. PMID: 2276680 Review.

3

Effects of recombinant alpha and gamma interferons on the in vitro growth of circulating hematopoietic progenitor cells (CFU-GEMM, CFU-Mk, BFU-E, and CFU-GM) from patients with myelofibrosis with myeloid metaplasia.

Carlo-Stella C, Cazzola M, Gasner A, Barosi G, Dezza L, Meloni F, Pedrazzoli P, Hoelzer D, Ascari E. Carlo-Stella C, et al. Among authors: barosi g. Blood. 1987 Oct;70(4):1014-9. Blood. 1987. PMID: 3115331 Free article.

4

Natural history of idiopathic refractory sideroblastic anemia.

Cazzola M, Barosi G, Gobbi PG, Invernizzi R, Riccardi A, Ascari E. Cazzola M, et al. Among authors: barosi g. Blood. 1988 Feb;71(2):305-12. Blood. 1988. PMID: 3337899 Free article.

5

Regulation of erythropoietin production in a case of congenital erythropoietin-dependent pure erythrocytosis.

Borgna-Pignatti C, Liberato NL, Marradi P, Rosti V, Barosi G. Borgna-Pignatti C, et al. Among authors: barosi g. Am J Hematol. 1994 Aug;46(4):348-53. doi: 10.1002/ajh.2830460417. Am J Hematol. 1994. PMID: 8037189

6

Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.

Cazzola M, Ponchio L, de Benedetti F, Ravelli A, Rosti V, Beguin Y, Invernizzi R, Barosi G, Martini A. Cazzola M, et al. Among authors: barosi g. Blood. 1996 Jun 1;87(11):4824-30. Blood. 1996. PMID: 8639855 Free article.

7

Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.

Locatelli F, Pedrazzoli P, Barosi G, Zecca M, Porta F, Liberato L, Gambarana D, Nespoli L, Cazzola M. Locatelli F, et al. Among authors: barosi g. Br J Haematol. 1992 Apr;80(4):545-9. doi: 10.1111/j.1365-2141.1992.tb04571.x. Br J Haematol. 1992. PMID: 1581240

8

An atypical myeloproliferative disorder with high thrombotic risk and slow disease progression.

Barosi G, Buratti A, Costa A, Liberato LN, Balduini C, Cazzola M, Rosti V, Magrini U, Ascari E. Barosi G, et al. Cancer. 1991 Nov 15;68(10):2310-8. doi: 10.1002/1097-0142(19911115)68:10<2310::aid-cncr2820681034>3.0.co;2-2. Cancer. 1991. PMID: 1913467

9

[Cytoreductive effect of recombinant alfa-interferon in patients with myelofibrosis with myeloid metaplasia].

Barosi G, Liberato NL, Costa A, Ascari E. Barosi G, et al. Haematologica. 1990 Jul-Aug;75 Suppl 4:48-50. Haematologica. 1990. PMID: 2074054 Italian. No abstract available.

10

Cytoreductive effect of recombinant alpha interferon in patients with myelofibrosis with myeloid metaplasia.

Barosi G, Liberato LN, Costa A, Ascari E. Barosi G, et al. Blut. 1989 Jun;58(6):271-4. doi: 10.1007/BF00320164. Blut. 1989. PMID: 2736307

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

380 results

Search Page

Filters